On September 4, 2020 Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, reported that management will be participating in the following investor conferences in September 2020 (Press release, Pliant Therapeutics, SEP 4, 2020, View Source [SID1234564513]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 15th Annual BioPharma Conference on September 8-11, 2020. Pliant’s Scott Turner, Ph.D., will be on a panel discussing COVID-19 therapeutics on Wednesday, September 9 at 9:50 a.m. EDT.
Cantor Fitzgerald’s Virtual Global Healthcare Conference on September 15-17, 2020.
Company presentations and webcast replays will be available directly on the conference event platform or the Pliant Therapeutics Investors page: View Source

On September 4, 2020 Cygnal Therapeutics, the first company to build a platform to develop drugs in the new field of exoneural biology, reported that Pearl Huang, Ph.D., President and Chief Executive Officer, will present a company overview as part of Wells Fargo’s 2020 Virtual Healthcare Conference on Wednesday, September 9, 2020 at 3:20 p.m. E.T (Press release, Cygnal Therapeutics, SEP 4, 2020, View Source [SID1234564512]). The event will be held virtually. Registration is available for clients through Wells Fargo.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

On September 4, 2020 ViewRay, Inc. (NASDAQ: VRAY) reported that the Company will participate in three upcoming virtual investor conferences (Press release, ViewRay, SEP 4, 2020, View Source [SID1234564511]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: Cantor Virtual Global Healthcare Conference

Format: Virtual 1×1 Meetings

Date: Wednesday, September 16, 2020

Event: Morgan Stanley 18th Annual Global Healthcare Conference

Format: Virtual Fireside Chat & 1×1 Meetings

Date: Friday, September 18, 2020

Time: 11:00 am ET

Link: View Source

Event: Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Format: Virtual Fireside Chat & 1×1 Meetings

Date: Wednesday, September 23, 2020

Time: 2:30 pm ET

Link: View Source

A replay of the fireside chats will be available for 14 days after the date of the presentation at View Source.

On September 4, 2020 Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, reported that Vu Truong, Ph.D., Chief Executive Officer, will present at the following investor conferences in September (Press release, Aridis Pharmaceuticals, SEP 4, 2020, View Source [SID1234564510]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2020 Cantor Fitzgerald Virtual Global Healthcare Conference on Tuesday, September 15, 2020 at 9:20 AM EDT
H.C. Wainwright 22nd Annual Global Investment Conference on Tuesday, September 15, 2020 at 3:30 PM EDT
A webcast of the Cantor Fitzgerald presentation will be available at View Source A replay of the webcast will be available on the Company’s website for 90 days following the event.

On September 4, 2020 Amgen (NASDAQ:AMGN) reported that it will present at Citi’s 15th Annual Virtual BioPharma Conference at 2:25 p.m. ET on Thursday, Sept. 10, 2020. Murdo Gordon, executive vice president of Global Commercial Operations at Amgen and Peter H. Griffith, executive vice president and chief financial officer, will present at the conference (Press release, Amgen, SEP 4, 2020, View Source [SID1234564509]). Live audio of the presentation can be accessed from the Events Calendar on Amgen’s website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen’s website for at least 90 days following the event.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!